Hennion & Walsh Asset Management’s Instil Bio TIL Stock Holding History

Hennion & Walsh Asset Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,904	Closed	-$42K	–	872
2023 Q3	$42K	Buy	4,904 +195	+4%	+$1.97K	﹤0.01%	798
2023 Q2	$52K	Sell	4,709 -127	-3%	-$1.55K	﹤0.01%	794
2023 Q1	$64K	Sell	4,836 -153	-3%	-$2.26K	﹤0.01%	768
2022 Q4	$63K	Buy	4,989 +621	+14%	+$30.7K	﹤0.01%	763
2022 Q3	$423K	Buy	4,368 +1,088	+33%	+$124K	0.03%	518
2022 Q2	$303K	Buy	+3,280	New	+$465K	0.02%	624

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hennion & Walsh Asset Management's TIL Position: Q4 2023 in Review

Hennion & Walsh Asset Management sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 4,904 shares — an estimated $42K sold.

Hennion & Walsh Asset Management first reported a position in TIL in Q2 2022 and held it in 6 quarters. The position peaked at $423K in Q3 2022. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

Hennion & Walsh Asset Management reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
Hennion & Walsh Asset Management sold 4,904 Instil Bio shares in Q4 2023, an estimated $42K.
Hennion & Walsh Asset Management first reported a position in Instil Bio in Q2 2022 and held it in 6 quarters.
Hennion & Walsh Asset Management's Instil Bio position peaked at $423K in Q3 2022.
30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.